About LabCyte
LabCyte is a company based in Sunnyvale (United States) founded in 2000 was acquired by Beckman Coulter in January 2019. LabCyte has raised $33.39 million across 8 funding rounds from investors including SVB, Beckman Coulter and Credit Suisse. The company has 184 employees as of December 31, 2022. LabCyte has completed 1 acquisition, including Deerac Fluidics. LabCyte operates in a competitive market with competitors including Opentrons, Tecan, Andrew Alliance, Scienion and Flow Robotics, among others.
- Headquarter Sunnyvale, United States
- Employees 184 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Labcyte Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.39 M (USD)
in 8 rounds
-
Latest Funding Round
$5 M (USD), Series D
Jan 03, 2017
-
Investors
SVB
& 13 more
-
Employee Count
184
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Beckman Coulter
(Jan 30, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of LabCyte
Unlock access to complete
Funding Insights of LabCyte
LabCyte has successfully raised a total of $33.39M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $5 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LabCyte
LabCyte has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Beckman Coulter and Credit Suisse.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
Early stage venture capital firm investing in US
|
Locked | Locked | Locked | |
|
Early stage venture capital firm investing in the US
|
Locked | Locked | Locked |
Investor details for LabCyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LabCyte
LabCyte has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Deerac Fluidics.
Investment portfolio details for LabCyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Fluidic systems are engineered for scientific and research applications.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for LabCyte
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - LabCyte
Detailed financials for LabCyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Labcyte Comparisons
Peer comparison for LabCyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LabCyte
LabCyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, Tecan, Andrew Alliance, Scienion and Flow Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pipetting robots for laboratory automation are developed.
|
|
| Locked | Locked | Locked |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| Locked | Locked | Locked |
Provider of automated liquid handling tools and software for scientific labs
|
|
| Locked | Locked | Locked |
Non-contact dispensing solutions for genomics and proteomics are provided.
|
|
| Locked | Locked | Locked |
AI-based robots for laboratory liquid handling automation are provided.
|
Detailed competitors of LabCyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Labcyte
Complete news archive for LabCyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LabCyte
LabCyte was founded in 2000 and raised its 1st funding round 2 years after it was founded.
LabCyte is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
LabCyte is a funded company, having raised a total of $33.39M across 8 funding rounds to date.
As of Dec 31, 2022, the latest employee count at LabCyte is 184.
LabCyte is a developer of acoustic liquid handling for life science research. Its products use acoustic energy to transfer precise amounts of fluids without touching them. This capability improves data quality and reliability, while eliminating or substantially reducing costs associated with pipette tips, reagents and waste disposal. Also, it conserves precious samples and enables highly accurate assay miniaturization, dramatically improving productivity. Labcyte products offers solutions for: High throughput and secondary screening, Cell-based and biochemical assays and ADME-Tox, Genomics Next-Gen sequencing, RT-qPCR and genotyping Proteomics-Proteinpeptide arrays, biomarkers, and protein crystallography.
LabCyte's top competitors include Opentrons, Tecan and Andrew Alliance.
LabCyte has made 1 acquisition, including Deerac Fluidics.
LabCyte has 14 investors. Key investors include SVB, Beckman Coulter, Credit Suisse, NIH, and General Electric.